Clinical Trial Update: Design of Personalised SupplemenTs Based on the Gut MicRobiota Through Artificial Intelligence for Alzheimer's Patients [NA]

View source ↗

Summary

Clinical trial design update on personalized gut microbiota–based supplements for Alzheimer's disease using artificial intelligence; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: Universidad Complutense de Madrid | Conditions: Alzheimer Disease, Gut Microbiota | NA | Status: RECRUITING